• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

香豆素治疗患者血浆中一系列部分羧化的凝血酶原。

A spectrum of partially carboxylated prothrombins in the plasmas of coumarin-treated patients.

作者信息

Friedman P A, Rosenberg R D, Hauschka P V, Fitz-James A

出版信息

Biochim Biophys Acta. 1977 Sep 27;494(1):271-6. doi: 10.1016/0005-2795(77)90155-6.

DOI:10.1016/0005-2795(77)90155-6
PMID:901810
Abstract

Prothrombin has been purified from the plasmas of normal human donors and from patients ingesting coumarins. Equimolar amounts of normal prothrombin or coumadin-induced prothrombin were incubated with phospholipid micelles in the presence of Ca2+. Subsequent gel filtration of the incubation mixtures demonstrated that all of the normal prothrombin was bound to the phospholipid; only half of the coumadin-induced prothrombin was bound. Normal prothrombin contains approximately 10 mol of gamma-carboxyglutamic acid per mol of prothrombin. The coumadin-induced prothrombin which was bound to phospholipid contains approximately 6.5 mol of gamma-carboxyglutamic acid per mol of prothrombin while that which failed to bind to phospholipid has only 2.8 mol of gamma-carboxyglutamic acid per mol of zymogen. Thus, partially carboxylated prothrombins exist in the plasmas of coumarin-treated patients. Furthermore, there is a striking electrophoretic heterogeneity in the prothrombin preparations from the plasmas of the coumadin-treated patients. This most likely results from a wide spectrum of abnormal prothrombins with varying quantities of gamma-carboxyglutamic acid per mol of zymogen.

摘要

已从正常人类供体血浆以及服用香豆素的患者血浆中纯化出凝血酶原。将等摩尔量的正常凝血酶原或香豆素诱导的凝血酶原在Ca2+存在的情况下与磷脂微团一起孵育。随后对孵育混合物进行凝胶过滤,结果表明所有正常凝血酶原均与磷脂结合;而香豆素诱导的凝血酶原只有一半与磷脂结合。每摩尔凝血酶原中,正常凝血酶原约含10摩尔γ-羧基谷氨酸。与磷脂结合的香豆素诱导的凝血酶原,每摩尔凝血酶原约含6.5摩尔γ-羧基谷氨酸,而未与磷脂结合的香豆素诱导的凝血酶原,每摩尔酶原仅含2.8摩尔γ-羧基谷氨酸。因此,香豆素治疗患者的血浆中存在部分羧化的凝血酶原。此外,香豆素治疗患者血浆中的凝血酶原制剂存在明显的电泳异质性。这很可能是由于每摩尔酶原中γ-羧基谷氨酸含量不同的多种异常凝血酶原所致。

相似文献

1
A spectrum of partially carboxylated prothrombins in the plasmas of coumarin-treated patients.香豆素治疗患者血浆中一系列部分羧化的凝血酶原。
Biochim Biophys Acta. 1977 Sep 27;494(1):271-6. doi: 10.1016/0005-2795(77)90155-6.
2
The kinetics of activation of normal and gamma-carboxyglutamic acid-deficient prothrombins.
J Biol Chem. 1985 Jan 10;260(1):279-87.
3
Distribution of gamma-carboxyglutamic acid residues in partially carboxylated human prothrombins.γ-羧基谷氨酸残基在部分羧化的人凝血酶原中的分布
J Biol Chem. 1986 Feb 5;261(4):1624-8.
4
Partially carboxylated prothrombins. I. Comparison of activation properties and purification of 1- and 0-carboxyglutamyl variants.
Biochim Biophys Acta. 1982 Apr 3;702(2):178-84. doi: 10.1016/0167-4838(82)90500-3.
5
Partially carboxylated prothrombins. II. Effect of gamma-carboxyglutamyl residues on the properties of prothrombin fragment 1.部分羧化的凝血酶原。II. γ-羧基谷氨酸残基对凝血酶原片段1性质的影响。
Biochim Biophys Acta. 1982 Apr 3;702(2):185-92. doi: 10.1016/0167-4838(82)90501-5.
6
The importance of specific gamma-carboxyglutamic acid residues in prothrombin. Evaluation by site-specific mutagenesis.凝血酶原中特定γ-羧基谷氨酸残基的重要性。通过定点诱变进行评估。
J Biol Chem. 1993 Nov 15;268(32):24339-45.
7
Metal and phospholipid binding properties of partially carboxylated human prothrombin variants.
J Biol Chem. 1985 Aug 5;260(16):9258-64.
8
The functional significance of vitamin K action. Difference in phospholipid binding between normal and abnormal prothrombin.维生素K作用的功能意义。正常与异常凝血酶原之间磷脂结合的差异。
J Biol Chem. 1975 Jun 10;250(11):4095-9.
9
The interaction of prothrombin with phospholipid membranes is independent of either kringle domain.凝血酶原与磷脂膜的相互作用独立于任何一个kringle结构域。
J Biol Chem. 1993 Jul 25;268(21):15633-9.
10
Dicoumarol-induced prothrombins containing 6, 7, and 8 gamma-carboxyglutamic acid residues: isolation and characterization.
Biochem Cell Biol. 1989 Aug;67(8):411-21. doi: 10.1139/o89-066.

引用本文的文献

1
Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines.当代抗血小板和抗凝治疗用于二级卒中预防:当前文献和指南的叙述性综述。
Curr Neurol Neurosci Rep. 2023 May;23(5):235-262. doi: 10.1007/s11910-023-01266-2. Epub 2023 Apr 11.
2
New versus Old Oral Anticoagulants: How Can We Set the Scale Needle? Considerations on a Case Report.新型与旧型口服抗凝药物:我们如何调整天平的指针?基于一则病例报告的思考。
Medicina (Kaunas). 2019 Mar 17;55(3):71. doi: 10.3390/medicina55030071.
3
Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis.
维生素 K 逆转维生素 K 拮抗剂抗凝过度:系统评价和荟萃分析。
Blood Adv. 2019 Mar 12;3(5):789-796. doi: 10.1182/bloodadvances.2018025163.
4
Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type.根据口服抗凝剂类型的脑出血体积及功能预后
Neurology. 2016 Jan 26;86(4):360-6. doi: 10.1212/WNL.0000000000002310. Epub 2015 Dec 30.
5
Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine.颅内出血中抗栓药物逆转指南:神经重症监护学会和危重症医学会给医疗保健专业人员的声明
Neurocrit Care. 2016 Feb;24(1):6-46. doi: 10.1007/s12028-015-0222-x.
6
Algorithm for anticoagulation management in geriatric hip fracture patients--Surgeons save Blood.老年髋部骨折患者抗凝管理算法——外科医生节约用血
Z Gerontol Geriatr. 2014 Feb;47(2):95-104. doi: 10.1007/s00391-013-0595-4.
7
Membrane binding by prothrombin mediates its constrained presentation to prothrombinase for cleavage.凝血酶原与膜的结合介导了其向凝血酶原酶的受限呈递以进行裂解。
J Biol Chem. 2013 Sep 27;288(39):27789-800. doi: 10.1074/jbc.M113.502005. Epub 2013 Aug 12.
8
Reversal of oral anticoagulation.口服抗凝治疗的逆转
Pharmacotherapy. 2013 Nov;33(11):1199-213. doi: 10.1002/phar.1270. Epub 2013 Apr 18.
9
Review on natural coumarin lead compounds for their pharmacological activity.天然香豆素先导化合物的药理活性研究进展。
Biomed Res Int. 2013;2013:963248. doi: 10.1155/2013/963248. Epub 2013 Mar 24.
10
[Role of vitamin K antagonists from a hepatologist's point of view].
Herz. 2012 Jun;37(4):395-401. doi: 10.1007/s00059-012-3620-2.